Improving ADHD treatment adherence for minority children through family navigation
Official title: A Family Navigator Intervention to Improve ADHD- Related Treatment Adherence (I2-ART) for Minority Children
Run by Children's Hospital Medical Center, Cincinnati · NCT04591951 · Data updated 2026-05-14
This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.
This study is testing a new program to help African American and Latinx families with children who have ADHD stick to their treatment plans better.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 108 (estimated) |
| Sponsor | Children's Hospital Medical Center, Cincinnati Academic / other |
| Locations | 1 site (Cincinnati, Ohio) |
| Trial ID | NCT04591951 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are Latinx and African American caregivers of children aged 7-11 years who are treatment-naïve for ADHD.
✕Probably not a fit
Patients who do not speak English or Spanish may not benefit from this study due to language barriers.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This project aims to enhance treatment adherence for minority children with ADHD by developing and testing the I2-ART intervention. The intervention is based on the Parent Empowerment Program (PEP) and will be tailored specifically for African American and Latinx families. The study will involve focus groups with caregivers, clinicians, and family navigators to identify barriers and facilitators to treatment adherence. The findings will inform the implementation of the intervention in subsequent phases.
Why it matters
Potential benefit: If successful, this intervention could significantly improve treatment adherence and outcomes for minority children with ADHD.
How similar studies have gone: While there have been studies focusing on ADHD treatment adherence, this specific approach using family navigation for minority populations is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
1. Clinicians. Inclusion Criteria: * Currently providing care for children with ADHD as psychologists, general pediatricians, or developmental pediatricians. * \> 18 years old. * Any race/ethnicity. Exclusion Criteria: \* Unable to read/speak either English or Spanish. 2. Family navigators. Inclusion Criteria: * Having experience working as family navigator and/or community health worker. * Latinx (Lx) or African American (AA). * \> 18 years old. Exclusion Criteria: \* Unable to read/speak either English or Spanish. 3. Caregivers. Inclusion Criteria: * Phase 1a: current or former caregiver of a child with ADHD, with and without experience with ADHD treatment. * Phases 1b and 2: current caregiver of a child (aged 7-11 years) with ADHD who is ADHD treatment-naïve at study enrollment. * Lx or AA. * \> 18 years old. Exclusion Criteria: \* Unable to read/speak either English or Spanish.
Where it's running
-
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio, United States Recruiting
Study contacts
- Principal investigator: Kelly Kamimura-Nishimura, MD — Children's Hospital Medical Center, Cincinnati
- Study coordinator: Kelly Kamimura-Nishimura
- Email: kelly.kamimura-nishimura@cchmc.org
- Phone: 513-636-7594
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Foquest in older adults with ADHD: daily methylphenidate for 65+
This study tests whether once-daily Foquest helps symptoms in adults 65 and older with ADHD.
-
Neuroplasticity-targeted supplements for ADHD in children
A 12-week randomized trial tests whether gut- and brain-targeted supplements can help reduce ADHD symptoms in children aged 6–12.
-
Therapy approaches for irritability in youths: active treatments vs nonactive psychoeducation
This study tests whether active psychotherapies for irritability in kids aged 8–16.5 years work better than nonactive, time-matched psychoeducation for children and their parents.
-
Playful physiotherapy to support children with ADHD or autism
This program will try a play-based physiotherapy approach to see if it improves emotional, behavioral, and social functioning in Estonian-speaking children aged 5–12 with ADHD or autism.
-
Social cognition testing for 8–16-year-olds with autism, ADHD, or atypical development
This project will test a multidimensional social-cognition battery in French-speaking 8–16-year-olds with autism, ADHD, or atypical neurodevelopment to see if it better identifies social processing differences.
-
Transcranial infrared light to the prefrontal cortex for adults with ADHD
This trial will try using transcranial infrared light on the prefrontal cortex to see if it improves attention, impulse control, and working memory in adults with ADHD.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.